China approves AstraZeneca, Sanofi shot to prevent RSV infection
时间:2024-06-26 07:21:56 阅读(143)
China approved a shot co-developed by AstraZeneca Plc and Sanofi to ward off respiratory syncytial virus in a broad swath of infants, a first in the nation to thwart the highly contagious and potentially fatal infection.
The National Medical Products Administration cleared the long-acting monoclonal antibody Beyfortus to prevent RSV infections in newborns, Astra said in a statement on Tuesday. While RSV has been circulating in China for months, the shot isn’t expected to be available until the upcoming 2024-2025 season, the company said.
RSV causes inflammation of the airways that can lead to difficulty breathing and death in rare cases. Beyfortus is among the first medicines available for widespread use to protect infants from the illness, which affects most children by the age of two.
China has confronted an outsized outbreak of respiratory diseases since the second half of 2023, with children particularly hard hit by a barrage of common pathogens including RSV, flu and mycoplasma pneumoniae. The surge in disease has stretched some pediatric medical centers across the country beyond capacity.
猜你喜欢
- Share Market Highlights- Nifty settles above 17700, Sensex tanks 500 pts; Bank Nifty ends above 42250, IT index falls 5%
- Share Market HIGHLIGHTS- Sensex crashes 844 pts, Nifty ends at 16984 as bears dominate D-St; Reliance drags
- Banking, NBFC stocks jump after RBI MPC meet; Banking shares outlook bullish, NBFCs to benefit
- Share Market Highlights- Nifty under 17950, Sensex down 300 pts, snap 3-day winning streak; Bank Nifty 1
- Share Market Highlights- Nifty settles above 19800, Sensex above 66000, Pharma and Healthcare stocks shed
- Share Market Highlights- Nifty trades below 19,750, Sensex above 65,900 ; Nifty Bank down over 100 points
- Avesh Khan replaces Mohammad Shami for second test against South Africa
- Share Market Crash Highlights- Nifty settles below 17560, Sensex tanks 900 pts; Bank Nifty closes below 40000
- Share Market Highlights- Nifty settles above 19800, Sensex above 66000, Pharma and Healthcare stocks shed